Share Prices & Company Research

Stockbroking

ImmuPharma

Current Price 7.72p Bid 7.71p Ask 8.15p Change -5.65%
Last Updated: 18/11/2019 12:29. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

ImmuPharma PLC (formerly General Industries PLC) is developing innovative therapies for specialist diseases, It is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by: High unmet medical need; Low marketing costs; Relatively low development costs.. Founded first in Basel, Switzerland in 1999 and led by an experienced management team, ImmuPharma now has important R&D collaboration arrangements with highly respected health and medical research laboratories in Europe. The company plans either to bring its drug candidates to market itself, or to license them in corporate deals to other pharmaceutical companies.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.08m
Operating Profit
£-8.08m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-1.62

Key Personnel

Dimitri F Dimitriou
Chief Executive Officer
Dr Robert Henri Zimmer
Chief Scientific Officer
Timothy Paul McCarthy
Non-Executive Chairman
Dr Franco di Muzio
Non-Executive Director
Dr Stephane Robert George Mery
Non-Executive Director

Stock Details

EPIC
IMM
ISIN
GB0033711010
Shares in Issue
167,360,920
Market cap
£14.08m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
7.93p
Bid Price
7.71p
Ask Price
8.15p
Volume
96636
Change Today
-0.48p
% Change Today
-5.65%
Open
8.30p
Previous Close
8.41p
Intraday High
8.55p
Intraday Low
7.72p
52 Week High
21.50p
52 Week Low
7.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

ImmuPharma Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
0.2
0.2
Intangible Assets & Goodwill
0.5
0.5
Investments & Other Non-Current Assets
2.0
0.0
Total Non-Current Assets
2.7
0.6
Inventory
0.0
0.0
Trade & Receivables
0.3
0.7
Cash & Receivables
4.9
2.7
Other Current Assets & Assets Held for Resale
0.8
0.9
Total Assets
8.7
5.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
1.0
1.1
Long Term Liabilities
0.0
0.3
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1.0
1.4

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
7.6
3.6

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
14.0
13.3
Minority Interests
0.0
0.0
Retained Earnings
-32.8
-25.6
Share Premium Account
27.3
18.7
Other Equity
-0.9
-2.9
Total Equity
7.6
3.6

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-4.7
-4.4
Cashflow Before Financing
-6.8
-4.5
Increase / Decrease in Cash
2.3
1.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
0.1
0.2
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-8.1
-7.2
Pre-Tax Profit
-8.0
-7.0
Profit / Loss for the Year
-7.2
-6.2
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.